Schedule 13G ownership disclosure

NEKTAR THERAPEUTICS

Security class unavailable · CUSIP: 640268108

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,357,522
Percent of class
14.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-012403
Form type
SC 13G/A
Filer
NEKTAR THERAPEUTICS
CIK
CIK 906709
Filed
Feb 27, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub